Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private providers

Cancer
J Kellogg ParsonsMark S Litwin

Abstract

The authors compared the types of treatments prostate cancer patients received from county hospitals and private providers as part of a statewide public assistance program. This was a cohort study of 559 men enrolled in a state-funded program for low-income patients known as Improving Access, Counseling, and Treatment for Californians With Prostate Cancer (IMPACT). Multinomial regression was used to compare types of treatments patients received from different providers. Between 2001 and 2006, 315 (56%) participants received treatment from county hospitals and 244 (44%) from private providers. There were no significant between-group differences with respect to age (P = .22), enrollment year (P = .49), Charlson comorbidity index (P = .47), Gleason sum (P = .33), clinical T stage (P = .36), prostate-specific antigen (P = .39), or D'Amico risk criteria (P = .45). Participants treated by private providers were more likely than those treated in county hospitals to be white (35% vs 10%, P < .01) and less likely to undergo surgery (29% vs 54%, P < .01). Multinomial regression analyses showed that participants treated by private providers were nearly 2(1/2) times more likely than those treated by public providers to receive radiotherapy...Continue Reading

References

Jun 24, 2000·JAMA : the Journal of the American Medical Association·F J FowlerM J Barry
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin A SpencerMark S Litwin
Sep 16, 2004·Journal of the National Cancer Institute·Arnold L PotoskyLinda C Harlan
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David C MillerJohn T Wei
May 5, 2005·JAMA : the Journal of the American Medical Association·Peter C AlbertsenJudith Fine
Jul 15, 2005·JAMA : the Journal of the American Medical Association·Nima SharifiWilliam L Dahut
May 19, 2007·The Journal of Urology·David F PensonUNKNOWN Urologic Diseases in America Project
Mar 21, 2008·The New England Journal of Medicine·Martin G SandaJohn T Wei
Aug 16, 2008·Cancer·Benjamin D SommersRichard J Zeckhauser
Dec 23, 2008·The Journal of Urology·David C MillerWilliam J Aronson
Jan 1, 2006·The Libyan Journal of Medicine·Riyad Bendardaf

❮ Previous
Next ❯

Citations

Sep 22, 2011·Journal of General Internal Medicine·Karim ChamieMark S Litwin
Jan 20, 2016·Prostate Cancer and Prostatic Diseases·C CaryM R Cooperberg
Dec 1, 2011·Urologic Oncology·Karim ChamieMark S Litwin
Jun 1, 2011·Cancer·Ravishankar JayadevappaS Bruce Malkowicz
Jun 5, 2016·Actas urologicas españolas·J M Martínez-JabaloyasUNKNOWN Grupo Español de Cáncer de Próstata

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.